NHS in landmark talks with UK private hospital
This article was originally published in Clinica
National Health Service patients will, from April 2002, begin to receive treatment from a private hospital, the UK Department of Health expects. It follows the announcement that the government is in "active negotiations" with private health group BUPA Hospitals over the creation and management of the first of 20 "fast-track" diagnostic and treatment centres (DTCs).
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.